Mechanisms of IL-17 Mediated Host Defense in the Kidney
IL-17 介导的肾脏宿主防御机制
基本信息
- 批准号:9023669
- 负责人:
- 金额:$ 30.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-20 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:A MouseAbdomenAcuteAdultAgonistAngiotensin-Converting Enzyme InhibitorsAnimal ModelAntifungal AgentsApplications GrantsBiochemicalBlood PressureBradykininBradykinin ReceptorCandidaCandida albicansCandidiasisCatheterizationCellsCessation of lifeChromatinChronicCleaved cellClinicalClinical TrialsDataDiagnosisDiseaseDisseminated candidiasisDistalDrug TargetingDrug resistanceEpithelial CellsEquilibriumExperimental ModelsFDA approvedFibrosisGene ExpressionGene TargetingGoalsHematopoietic Stem Cell TransplantationHost DefenseHost Defense MechanismHumanHyphaeImmune systemImmunityIndwelling CatheterInfectionInflammationInjuryInterleukin-17InterventionInvadedKallikrein-Kinin SystemKidneyKidney DiseasesKidney FailureKininogenaseKininogensKnowledgeLifeLinkLiverMalignant NeoplasmsMediatingMediator of activation proteinModalityMorbidity - disease rateMouse StrainsMucous MembraneMusNosocomial InfectionsOperative Surgical ProceduresOral cavityOrganOxidation-ReductionPathogenesisPathologyPathway interactionsPatientsPremature BirthRNA InterferenceRegulationRenal functionReportingResearchResistanceRoleSeriesSerine ProteaseSignal PathwaySignal TransductionSolidSterilitySystemSystemic diseaseTherapeuticTherapeutic immunosuppressionTissuesTreatment EfficacyTubular formationUrinary KallikreinVaccinescandidemiacell typecombatcytokineeffective therapyfungusin vivoinhibitor/antagonistinsightkidney cellmortalitymouse modelneonatenew therapeutic targetnovelnovel therapeuticsoverexpressionpre-clinicalpreclinical studyprophylacticpublic health relevancereceptorresponsevaccine development
项目摘要
DESCRIPTION (provided by applicant): Candida albicans is a commensal fungus that resides in the oral cavity and gut mucosa. Normally, healthy humans efficiently control the colonization of Candida. However, in certain conditions such as solid organ and hematopoietic stem cell transplantation, receipt of immunosuppressive therapy, cancer, premature birth or indwelling catheterization, Candida albicans can disseminate and cause life-threatening systemic disease. In fact, disseminated candidiasis is the 4th most common nosocomial infection, with fatality rates up to 40-60%. The lack of effective vaccines and development of drug resistance act as major constraints in successfully treating these patients. Therefore, there is a serious unmet clinical need to develop better therapeutic and prophylactic strategies to combat these fatal infections. During disseminated infection, Candida hyphae invade target organs, particularly kidney and liver. Death from candidemia results from renal insufficiency in a substantial number of patients. While the contribution of mucosal immune system in anti-Candida host defense has been well studied in recent years, the role of local immunity in target organs, particularly the kidney, is largely overlooked. The cytokine IL-17 has emerged as a key mediator of host defense against Candida species. Both humans and experimental mouse models deficient in IL-17 pathways such as the IL-17 receptor A (IL-17RA) are susceptible to disseminated candidiasis. Our preliminary data show that IL-17RA signaling in non-hematopoietic cells is required for renal defense against systemic Candida infection. Nevertheless, the underlying mechanisms of IL-17-mediated host defense against systemic candidiasis particularly in the kidney are not known. Interestingly, we have discovered an unexpected role for IL-17 in inducing the Kallikrein-Kinin System (KKS) in kidney following candidemia. We also show that overexpression of Klk1 protects IL-17RA-/- mice from candidemia. Kallikreins are serine proteases that cleave kininogens to form bradykinin. The KKS system is known to be involved in renal protection against both acute and chronic kidney injury, but almost no connections of the KKS to candidiasis have been previously reported. The overall goal of this grant application is to determine the underlying mechanisms of IL-17-Klk1 mediated immunity during systemic candidiasis and ultimately to exploit this knowledge for therapeutic benefit. To that end, we will use a series of renal cell type specific gene-targeted mice, global Klk1 and bradykinin receptor-deficient mice and bradykinin receptor agonists to define mechanisms of IL-17-driven renal protection against candidemia (Aim 1). Knowledge gained from these studies will be used in pre-clinical studies to evaluate the therapeutic efficacy of targeting IL-17- KKS axis in kidney specific anti-fungal immunity (Aim 2). Our long term goal is to reduce the morbidity and mortality associated with this devastating hospital acquired infection.
性状(由申请方提供):白色念珠菌是一种寄生于口腔和肠道粘膜的真菌。正常情况下,健康人可以有效地控制念珠菌的定植。然而,在某些情况下,如实体器官和造血干细胞移植,接受免疫抑制治疗,癌症,早产或留置导管,白色念珠菌可传播并导致危及生命的全身性疾病。事实上,播散性念珠菌病是第四常见的医院感染,病死率高达40- 60%。缺乏有效的疫苗和耐药性的发展是成功治疗这些患者的主要制约因素。因此,存在严重的未满足的临床需求,以开发更好的治疗和预防策略来对抗这些致命感染。在播散性感染期间,念珠菌菌丝侵入靶器官,特别是肾脏和肝脏。在相当数量的患者中,肾功能不全导致念珠菌血症死亡。虽然近年来粘膜免疫系统在抗念珠菌宿主防御中的作用已经得到了很好的研究,但局部免疫在靶器官,特别是肾脏中的作用在很大程度上被忽视了。细胞因子IL-17已成为宿主防御念珠菌属物种的关键介质。缺乏IL-17途径如IL-17受体A(IL-17 RA)的人类和实验小鼠模型均易患播散性念珠菌病。我们的初步数据显示,非造血细胞中的IL-17 RA信号传导是肾脏防御系统性念珠菌感染所必需的。然而,IL-17介导的宿主防御系统性念珠菌病的潜在机制,特别是在肾脏是未知的。有趣的是,我们已经发现IL-17在念珠菌血症后诱导肾脏中的激肽释放酶-激肽系统(KKS)中的意想不到的作用。我们还表明Klk 1的过表达保护IL-17 RA-/-小鼠免受念珠菌血症。激肽释放酶是一种丝氨酸蛋白酶,可切割激肽原形成缓激肽。已知KKS系统参与肾脏保护以对抗急性和慢性肾损伤,但以前几乎没有报道KKS与念珠菌病的联系。这项资助申请的总体目标是确定系统性念珠菌病期间IL-17-Klk 1介导的免疫的潜在机制,并最终利用这些知识获得治疗益处。为此,我们将使用一系列肾细胞类型特异性基因靶向小鼠,全球Klk 1和缓激肽受体缺陷小鼠和缓激肽受体激动剂,以确定IL-17驱动的肾脏保护机制,防止念珠菌血症(目的1)。从这些研究中获得的知识将用于临床前研究,以评价靶向IL-17- KKS轴在肾特异性抗真菌免疫中的治疗效果(目的2)。我们的长期目标是降低与这种毁灭性的医院获得性感染相关的发病率和死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Partha Sarathi Biswas其他文献
Correction: Genomic prediction and QTL analysis for grain Zn content and yield in Aus-derived rice populations
- DOI:
10.1007/s13562-025-00983-8 - 发表时间:
2025-04-28 - 期刊:
- 影响因子:1.500
- 作者:
Tapas Kumer Hore;C. H. Balachiranjeevi;Mary Ann Inabangan-Asilo;C. A. Deepak;Alvin D. Palanog;Jose E. Hernandez;Glenn B. Gregorio;Teresita U. Dalisay;Maria Genaleen Q. Diaz;Roberto Fritsche Neto;Md. Abdul Kader;Partha Sarathi Biswas;B. P. Mallikarjuna Swamy - 通讯作者:
B. P. Mallikarjuna Swamy
Partha Sarathi Biswas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Partha Sarathi Biswas', 18)}}的其他基金
RNA binding proteins in end-organ autoimmune pathology
终末器官自身免疫病理学中的 RNA 结合蛋白
- 批准号:
10569112 - 财政年份:2022
- 资助金额:
$ 30.67万 - 项目类别:
RNA binding proteins in end-organ autoimmune pathology
终末器官自身免疫病理学中的 RNA 结合蛋白
- 批准号:
10450945 - 财政年份:2022
- 资助金额:
$ 30.67万 - 项目类别:
Mechanisms of renal protection against disseminated candidiasis
抵抗播散性念珠菌病的肾脏保护机制
- 批准号:
10376250 - 财政年份:2021
- 资助金额:
$ 30.67万 - 项目类别:
Mechanisms of renal protection against disseminated candidiasis
抵抗播散性念珠菌病的肾脏保护机制
- 批准号:
10190010 - 财政年份:2021
- 资助金额:
$ 30.67万 - 项目类别:
Mechanisms of neutrophil dysfunction in antifungal immunity
中性粒细胞功能障碍在抗真菌免疫中的机制
- 批准号:
10454893 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Mechanisms of neutrophil dysfunction in antifungal immunity
中性粒细胞功能障碍在抗真菌免疫中的机制
- 批准号:
9815169 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Mechanisms of neutrophil dysfunction in antifungal immunity
中性粒细胞功能障碍在抗真菌免疫中的机制
- 批准号:
10223106 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Mechanisms of neutrophil dysfunction in antifungal immunity
中性粒细胞功能障碍在抗真菌免疫中的机制
- 批准号:
10673766 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Regulation of IL-17 signaling by RNA binding proteins in kidney diseases
RNA 结合蛋白在肾脏疾病中调节 IL-17 信号传导
- 批准号:
9762270 - 财政年份:2019
- 资助金额:
$ 30.67万 - 项目类别:
Mechanisms of IL-17 Mediated Host Defense in the Kidney
IL-17 介导的肾脏宿主防御机制
- 批准号:
9144776 - 财政年份:2015
- 资助金额:
$ 30.67万 - 项目类别:
相似海外基金
Contributions of cell behaviours to dorsal closure in Drosophila abdomen
细胞行为对果蝇腹部背侧闭合的贡献
- 批准号:
2745747 - 财政年份:2022
- 资助金额:
$ 30.67万 - 项目类别:
Studentship
Using the GI Tract as a Window to the Autonomic Nervous System in the Thorax and in the Abdomen
使用胃肠道作为胸部和腹部自主神经系统的窗口
- 批准号:
10008166 - 财政年份:2018
- 资助金额:
$ 30.67万 - 项目类别:
Development of a free-breathing dynamic contrast-enhanced (DCE)-MRI technique for the abdomen using a machine learning approach
使用机器学习方法开发腹部自由呼吸动态对比增强 (DCE)-MRI 技术
- 批准号:
18K18364 - 财政年份:2018
- 资助金额:
$ 30.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Combined motion-compensated and super-resolution image reconstruction to improve magnetic resonance imaging of the upper abdomen
结合运动补偿和超分辨率图像重建来改善上腹部的磁共振成像
- 批准号:
1922800 - 财政年份:2017
- 资助金额:
$ 30.67万 - 项目类别:
Studentship
Optimising patient specific treatment plans for ultrasound ablative therapies in the abdomen (OptimUS)
优化腹部超声消融治疗的患者特定治疗计划 (OptimUS)
- 批准号:
EP/P013309/1 - 财政年份:2017
- 资助金额:
$ 30.67万 - 项目类别:
Research Grant
Optimising patient specific treatment plans for ultrasound ablative therapies in the abdomen (OptimUS)
优化腹部超声消融治疗的患者特定治疗计划 (OptimUS)
- 批准号:
EP/P012434/1 - 财政年份:2017
- 资助金额:
$ 30.67万 - 项目类别:
Research Grant
Relationship between touching the fetus via the abdomen of pregnant women and fetal attachment based on changes in oxytocin levels
基于催产素水平变化的孕妇腹部触摸胎儿与胎儿附着的关系
- 批准号:
16K12096 - 财政年份:2016
- 资助金额:
$ 30.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design Research of Healthcare System based on the Suppleness of Upper Abdomen
基于上腹部柔软度的保健系统设计研究
- 批准号:
16K00715 - 财政年份:2016
- 资助金额:
$ 30.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Technical Development of Diffusion Tensor Magnetic Resonance Imaging in the Human Abdomen
人体腹部弥散张量磁共振成像技术进展
- 批准号:
453832-2014 - 财政年份:2015
- 资助金额:
$ 30.67万 - 项目类别:
Postdoctoral Fellowships
Technical Development of Diffusion Tensor Magnetic Resonance Imaging in the Human Abdomen
人体腹部弥散张量磁共振成像技术进展
- 批准号:
453832-2014 - 财政年份:2014
- 资助金额:
$ 30.67万 - 项目类别:
Postdoctoral Fellowships














{{item.name}}会员




